Stay updated on Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial
Sign up to get notified when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.

Latest updates to the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page
- Check4 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden error, so the study details are not displayed. The page shows the error screen instead of the expected content.SummaryDifference21%

- Check11 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0, indicating a new release of the site's software. This change does not modify the study content displayed on the page.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.6.6 updated from v3.6.5 on the page, indicating a small maintenance update to the study details page.SummaryDifference0.0%

- Check32 days agoChange DetectedA funding identifier '2015 ( U.S. NIH Grant/Contract )' was added to the Study ID Numbers. This adds NIH funding attribution to the study record but does not change the study design or participant criteria.SummaryDifference0.0%

- Check46 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, representing a minor metadata/template update to the page without altering study content or results.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a new version of the page's documentation or UI. This change does not alter substantive content.SummaryDifference0.0%

Stay in the know with updates to Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.